| Patient | James Madison |
|---|---|
| Date of birth | 2003-03-16 |
| Identifiers | MRN HR-EN007-SYN; SSN (made up) 000-07-2618 |
| Document date | 2026-07-16 |
| Author | Josiah Pembroke-Achebe, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Preventive health visit at 23. [S]
Mr. Madison comes for his preventive visit. He completed the health risk questionnaire beforehand. He started sertraline five weeks ago; he had mild nausea for the first week, which settled, and no other side effects, and he has missed no doses. He has finished seven of his twelve psychotherapy sessions and keeps his event diary: he has had two brief events in the five weeks since his last visit, both at the end of long study days, and he used his grounding steps to cut one short. He is sleeping about seven hours with a fixed bedtime. He has not driven since his first visit. He has had no thoughts of death or self-harm, and the rifle remains locked with the ammunition stored separately. [S]
| Element | Detail |
|---|---|
| Visit | Preventive health visit, age 23 |
| Active conditions | Functional/dissociative seizures in psychotherapy; depression and anxiety on sertraline |
| Medicines | Sertraline 50 mg each morning |
| Screening history | No HIV, hepatitis B, or hepatitis C test on record; childhood vaccines complete |
Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Fair, improving |
| Psychosocial | Lives alone on a rural property; close friends; studying for the law school admission test |
| Behavioral | Never smoker; one or two drinks a month (AUDIT-C 1); no drugs; walks daily; regular meals |
| Injury prevention | Seat belt always as a passenger; not driving at present; no swimming alone |
| Firearms | One rifle, locked, with ammunition stored separately |
| Sexual health | Not sexually active in the past year; no known risk factors for sexually transmitted infection |
| Sleep | About seven hours with a fixed bedtime |
| Hearing and vision | No concerns |
| Dental | Dental check-up last year |
| Activities of daily living | Independent |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight 55.0 kg, up 1 kg; no fever |
| Eyes | Negative | No visual change |
| Ears, nose, mouth, and throat | Negative | No hearing loss |
| Cardiovascular | Negative | No palpitations, chest pain, or fainting on standing |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | Early nausea on sertraline settled; normal bowels |
| Genitourinary | Negative | No urinary or sexual side effects |
| Musculoskeletal | Negative | No joint pain |
| Integumentary | Negative | No changing moles; burns easily in the sun |
| Neurological | Positive | Two brief functional seizures in five weeks; no headache, weakness, or numbness |
| Psychiatric | Positive | Mood better; PHQ-9 8; worry less constant; no thoughts of death or self-harm |
11 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Levetiracetam 500 mg oral tablet, one tablet twice daily, started at an emergency department visit four months before intake for possible seizures, without an EEG | One tablet twice daily | Oral route | 2025-12-02 to 2026-04-30 | completed | S |
| Levetiracetam 500 mg oral tablet, taper: half a tablet (250 mg) twice daily for two weeks, then half a tablet at night for one week, then stop | Half a tablet twice daily for two weeks, then half a tablet at night for one week, then stop | Oral route | 2026-04-30 to 2026-05-21 | completed | S |
| Sertraline 50 mg oral tablet, half a tablet (25 mg) each morning for one week, then one tablet (50 mg) each morning | Half a tablet each morning for one week, then one tablet each morning | Oral route | 2026-06-11 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-07-16 | Body height | 168 | cm | S |
| 2026-07-16 | Body weight | 55 | kg | S |
| 2026-07-16 | Body mass index (BMI) [Ratio] | 19.5 | kg/m2 | S |
| 2026-07-16 | Systolic blood pressure | 114 | mm[Hg] | S |
| 2026-07-16 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-07-16 | Heart rate | 70 | /min | S |
| 2026-07-16 | Respiratory rate | 14 | /min | S |
| 2026-07-16 | Body temperature | 36.6 | Cel | S |
| 2026-07-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-07-16 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | {score} | S | ||
| 2026-07-16 | Total score [AUDIT-C] | 1 | {score} | S |
Vital signs recorded on 2026-07-16; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Slight build; BMI 19.5 |
| Skin | Fair skin; no atypical moles |
| Cardiovascular | Regular rhythm; no murmur; blood pressure 114/72 mmHg |
| Respiratory | Clear |
| Abdomen | Soft, non-tender |
| Psychiatric | Brighter; mood "steadier"; no suicidal ideation |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Recurrent sudden episodes of unresponsiveness for two years, two or three a month: he 'blanks out', stops speaking, slumps or sinks to the floor with his eyes closed for two to ten minutes, and afterwards is tearful and tired, with no tongue biting, incontinence, or injury; first during a period of overwork and little sleep at college; with low mood and anxiety; unchanged on levetiracetam; under evaluation for epilepsy, functional (dissociative) seizures, syncope, and other causes | resolved | confirmed | R40.4 | S — Synthetic presenting problem echoing his documented overwork, infirm health, and low spirits, and the later accounts of sudden attacks; superseded by the diagnosis at the second visit. |
| Taking an antiseizure medicine (levetiracetam) started without a confirmed diagnosis of epilepsy | resolved | confirmed | Z79.899 | S — Synthetic medication problem for teaching about avoiding unneeded antiseizure medicines; resolved when the medicine was stopped. |
| Functional/dissociative seizures (psychogenic nonepileptic seizures), documented by video-EEG: two habitual events captured with eyes closed and resisting opening, fluctuating unresponsiveness, and a normal waking EEG throughout, with no ictal or postictal change; normal interictal EEG and brain MRI; epilepsy and syncope excluded | active | confirmed | F44.5 | S — Synthetic modern diagnosis. His infirm health, overwork, and low spirits in youth are documented (D); retrospective explanations of his later attacks, including epilepsy, are disputed (R). This record does not assert what his attacks were. |
| Generalized anxiety disorder: worry about his future, his health, and his studies most days for more than a year, with restlessness, poor sleep, and muscle tension (GAD-7 14 at intake) | active | confirmed | F41.1 | S — Synthetic diagnosis made at the neuropsychiatric assessment during video-EEG monitoring. |
| Major depressive disorder, single episode, moderate: low mood, loss of interest, poor sleep and concentration, and a sense that he will not live long, for about eighteen months (PHQ-9 13 at intake); no suicidal ideation or intent | active | confirmed | F32.1 | S — Synthetic diagnosis echoing, without asserting, his documented letter expecting an early death. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Tetanus, diphtheria, and pertussis booster | Completed today | Tdap given today; adolescent dose eleven years ago |
| HPV vaccine | Up to date | Two-dose series completed at 12 |
| Meningococcal B vaccine | Declined | Shared decision at 16 to 23 discussed; no college residence or outbreak risk; he declined |
| Influenza and COVID-19 vaccines | Due | Due when this season's vaccines arrive in the autumn |
| Depression screening | Completed today | PHQ-9 8 while under treatment |
| Anxiety screening | Completed today | Generalized anxiety disorder under treatment; reviewed today |
| HIV screening | Ordered | One-time test at 15 to 65; never tested; ordered today |
| Hepatitis C screening | Ordered | One-time test at 18 to 79; ordered today |
| Hepatitis B screening | Ordered | One-time triple panel for all adults; ordered today |
| Blood pressure screening | Completed today | 114/72 mmHg |
| Unhealthy alcohol and drug use screening | Completed today | AUDIT-C 1; no drug use |
| Tobacco use | Completed today | Never smoker |
| Skin cancer prevention counseling | Completed today | Fair skin; sun protection advised |
| Lipid screening | Not indicated | Age 23 with no cardiovascular risk factors |
| Sexually transmitted infection screening | Not indicated | Not sexually active in the past year; no risk factors |
Immunizations given today: Tdap vaccine, adult booster [S]
Guideline basis: CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); Adult Immunization Schedule by Age (2026); Depression and Suicide Risk in Adults: Screening (2023); Anxiety Disorders in Adults: Screening (2023); Human Immunodeficiency Virus (HIV) Infection: Screening (2019); Hepatitis C Virus Infection in Adolescents and Adults: Screening (2020); Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations, United States, 2023 (2023); Unhealthy Drug Use: Screening (2020); Hypertension in Adults: Screening (2021)
Follow-up: Results by message; three-month review as booked; influenza and COVID-19 vaccines in the autumn. Next scheduled visit 2026-09-24: three-month review after completing psychotherapy: events, mood, driving, and his studies. [S]
Voluntary advance care planning discussion of about 16 minutes, with his consent. He has no directive. He names a close friend from college as his health care agent and took the state form. He would want full treatment for any illness he might recover from. He asked that information about his functional seizures be shared only with his care team and, in an emergency, with his agent, so that he is not given emergency antiseizure medicine for a typical event. [S]